These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1244 related articles for article (PubMed ID: 23144150)
1. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
2. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
3. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
4. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760 [TBL] [Abstract][Full Text] [Related]
5. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer. Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249 [TBL] [Abstract][Full Text] [Related]
6. Breath analysis in non small cell lung cancer patients after surgical tumour resection. Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311 [TBL] [Abstract][Full Text] [Related]
7. Optimization of volatile markers of lung cancer to exclude interferences of non-malignant disease. Zou Y; Zhang X; Chen X; Hu Y; Ying K; Wang P Cancer Biomark; 2014; 14(5):371-9. PubMed ID: 25171479 [TBL] [Abstract][Full Text] [Related]
8. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. Rudnicka J; Kowalkowski T; Ligor T; Buszewski B J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505 [TBL] [Abstract][Full Text] [Related]
9. Exhaled biomarkers in lung cancer. Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608 [TBL] [Abstract][Full Text] [Related]
10. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
11. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
12. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders. Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381 [TBL] [Abstract][Full Text] [Related]
13. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255 [TBL] [Abstract][Full Text] [Related]
14. The application of statistical methods using VOCs to identify patients with lung cancer. Ulanowska A; Kowalkowski T; Trawińska E; Buszewski B J Breath Res; 2011 Dec; 5(4):046008. PubMed ID: 22071773 [TBL] [Abstract][Full Text] [Related]
15. Breath testing as a method for detecting lung cancer. Taivans I; Bukovskis M; Strazda G; Jurka N Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216 [TBL] [Abstract][Full Text] [Related]
16. Breath biomarkers of liver cirrhosis. Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634 [TBL] [Abstract][Full Text] [Related]
17. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180 [TBL] [Abstract][Full Text] [Related]
18. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics. Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139 [TBL] [Abstract][Full Text] [Related]
19. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181 [TBL] [Abstract][Full Text] [Related]
20. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up. Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]